Ultragenyx Pharmaceutical reported $-121965000 in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -43.4M 23.03M
Acceleron Pharma XLRN:US $ -63.51M 0.05M
Agios Pharmaceuticals AGIO:US $ -82.79M 8.09M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -188.33M 10.94M
Aptinyx Inc APTX:US $ -19819000 5.59M
Bluebird Bio BLUE:US $ -231.42M 25.67M
Epizyme EPZM:US $ -64.36M 5.91M
Esperion Therapeutics ESPR:US $ -43668000 47.27M
Insmed INSM:US $ -116699000 25.3M
IONIS PHARMACEUT IONS:US $ -81M 8.74M
Karyopharm Therapeutics KPTI:US $ -53448000 3.82M
Kyowa Hakko Kirin 4151:JP Y 14942M 1218M
Macrogenics MGNX:US $ -39.94M 11.34M
Moderna Inc MRNA:US 3.06B 1.8B
Neurocrine Biosciences NBIX:US $ 57.5M 30.3M
Ptc Therapeutics PTCT:US $ -117.88M 10.31M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Sarepta Therapeutics SRPT:US $ -81.76M 85.63M
Ultragenyx Pharmaceutical RARE:US $ -121.96M 13.8M
Vital Therapies VTL:US $ -17.93M 16.6M
Xoma XOMA:US $ -2.24M 5.14M